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Abstract 
Background. Clinical governance is considered crucial in primary
care. Since 2005, clinical pathways have been experimentally imple-
mented at the Local Health Authority of Monza Brianza (ASLMB), Italy,
to develop general practitioners’ (GPs) care of patients affected by
some chronic diseases. The experimentation was aimed at introduc-
ing clinical governance in primary care, increasing GPs’ involvement
in the care of their patients, and improving both patients’ and profes-
sionals’ satisfaction. In the period 2005-2006, 12% of the 763 employed
GPs in the ASLMB were involved in the experiment, while this per-
centage increased to 15-20% in 2007-2008. 
Design and Methods. Twenty-four GPs were purposively sampled,
randomly divided into two groups and asked to participate in focus
groups (FGs) held in 2008, aimed at evaluating their perception of the
experiment. The FGs were audio-recorded, dialogues were typed out
and undergone to a thematic analysis, according to the Interpretative
Phenomenological Approach. 
Results. Four major themes emerged: i) clinical pathways can result
in GPs working in a more efficient and effective fashion; ii) they can
assure higher levels of both patient and professional satisfaction,
since they sustain a caring approach and strengthen the GPs’ role; iii)
nevertheless, clinical pathways increase the bureaucratic workload
and problems can arise in relationships among GPs and the LHA; iv)
the implementation of clinical pathways can be improved, especially
by reducing bureaucracy and by assuring their continuity.
Conclusions. Managerial aspects should be considered with care in
order to experimentally introduce clinical pathways in general prac-
tice, and continuity of the experimentation should be guaranteed to
improve GPs’ adherence and commitment.
Introduction
Since the seminal work by Starfield,1 the need to confront the
theme of remodelling health care systems, with attention to and
investment in the development of primary care, has been repeatedly
expressed.  This requires a re-evaluation of the role of the hospital
which should not be seen as the centre of the health system but rather
as an integrated part of a network including both primary and second-
ary level of care. This alone can overcome the fragmentation of assis-
tance that is so typical of complex health systems.2 Such a vision per-
meates national and regional decision-making. The recent Italian
National Health Policy 2011-2013 gave the priority to the reorganisa-
tion of care procedures that focus on the general public and clinical
governance.3
If correctly interpreted, clinical governance, as part of the reorgani-
sation, must aim to provide an adequate response to health needs and
a cohesive approach to shared professional guidelines. It is precisely
in the context of primary care that clinical governance finds its great-
est potential through taking responsibility not only for the single treat-
ment, but for the entire course of assistance to patients with chronic
diseases.
The development of guidelines to support the clinical management
of chronic conditions, such as diabetes, has become a well-established
practice.4 While guidelines are aimed at influencing  the general prac-
titioners’ (GPs) behaviour in diagnostic and therapeutic decisions by
widening physicians’ knowledge, clinical pathways also promote the
acquisition of skills (i.e. performing an ECG exam) in order to prevent,
diagnose and cure some chronic diseases. They are both aimed at
encouraging standardisation of good practices for all GPs. Despite this
laudable aim, the implementation of guidelines/clinical pathways does
not appear straightforward.4 Above all, just making the information
available has shown itself to be insufficient to guarantee uptake of
guidelines.5 In their systematic review, Majumdar et al.6 concluded
that adoption of guidelines can be hindered  by the very nature of evi-
dence that is often uncertain, limited and complex. Furthermore, GPs
can lack motivation to adopt guidelines because they are used to indi-
vidually apply their own knowledge evidence and dealing with compet-
ing pharmaceutical incentives; this is in addition to consumers’
demand or preference. Guidelines cannot be adopted due to lack of
time, resources and incentives. For example, a research conducted
with Australian GPs, who adopted guidelines in caring for diabetic
patients, has suggested that incentives do promote better clinical
management of those patients.7 Nevertheless, monetary reward is one
influence, but so are practical considerations, the desire to do the right
thing and having resources available.7 This means that, in order to
promote clinical pathways, several supporting factors need to be in
place. According to Saunders et al., these include: having a GP or other
driver within a practice who is promoting clinical pathways, the avail-
Significance for public health
Primary care is perceived as a crucial area in the delivery of health care
because of the necessity to improve the sustainability particularly of public,
universalistic health care systems moving from a hospital based resource
consuming pattern of care. GPs are seen as a key part of a multidisciplinary
team that can progressively assume a far more important role in the gover-
nance of their patients’ pathways. The analysis of GPs attitudes and feelings
about clinical pathways and clinical governance could help in making a step
forward in this process; by considering suggestions and feelings expressed
by professional bodies, policy makers can be helped in finding the best ways
to meet their objectives in the medium term. 
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ability of a practice nurse, and access to computers and databases.
Introducing clinical pathways in general practice requires changes to
be made to practice systems. GPs often perceive these changes to be
difficult to achieve in the midst of the pressures of patient workload.
Lack of time and paperwork are often cited as major barriers to intro-
ducing new clinical pathways in general practice. Above all, a flexible
approach to encouraging systematic management of chronic disease
should be carried forward. Prescriptive incentives from the top down
may have limited impact.7
As a consequence, interventions aimed at changing GPs’ behaviour
may not prove completely successful.8 Clinicians may prefer to manage
patients in accordance with established routines9 that endorse their
own autonomy. As Sanders et al. have stated, changing clinicians
behaviour does not solely depend on the proven effectiveness of the new
approach or its dissemination; contextual as well as occupational and
professional factors, such as doctors’ desire to retain their autonomy
over clinical decision making, may be critical to any attempts at intro-
ducing innovations in health care.9
Some GPs correlate this autonomy to the quality of doctor-patient rela-
tionship: whilst the imposition of a rational basis for clinical autonomy
might satisfy the requirements of the profession as a collective, it must
struggle against a patient-centred rhetoric and a process of cognitive trans-
formation that underpins everyday activity and the claimed autonomy of
the individual clinician.10 From this point of view, observing guidelines
may reduce the quality of the doctor-patient relationship. 
Interestingly, in their research aimed at defining quality criteria in
the management of common gastrointestinal disorders, starting from
patients’ views and practice guidelines, Jones et al.11 identified some
key themes: better provision of information for patients, better commu-
nication with and access to secondary care providers, and structured
follow up. These data seem to suggest that the introduction of guide-
lines in the management of common gastrointestinal disorders can
improve the quality of the doctor-patient relationship.
In any case, locally agreed pathways may be followed in preference to
national recommendations. In many countries, working groups com-
posed of specialists, faculty members and GPs have been constituted in
order to approve agreed pathways. For example, in Italy a working
group on how to manage the hypertensive patient was set up. In 2009,
it approved a clinical pathway on diagnostic tests, specialist evaluation,
preventive and non-pharmacological treatments, and drug treatment of
the hypertensive patient.12 Apart from being shared, guidelines are bet-
ter accepted when they make the job easier. Accordingly, a qualitative
study with English GPs in dealing with some guidelines, such as those
published by the British Thoracic Society for the care of asthma,
showed that they were welcomed.13 On the contrary, when guidelines
result in an increase in the doctors’ workloads, they are criticised.
However, when English GPs found that the nurse could actually do the
extra work required by a certain guideline, they greeted it with enthu-
siasm and agreed that it should have continued.13
Therefore, to improve guidelines, and consequently clinical gover-
nance, it is necessary to intervene on different levels, including the
organisational model that characterises general practice. The exami-
nation of this model in the Italian context identifies the still limited use
of associated forms in general medicine, while the experience of clini-
cal governance, although promising, has not been sufficiently evaluat-
ed and validated.14 The experience at the Local Health Authority (LHA)
of Monza Brianza (Azienda Sanitaria Locale di Monza Brianza,
ASLMB) since 2005, aimed at introducing clinical pathways in general
practice and is of interest for its size and complexity. 
Context of the study
The clinical pathways' experimentation was carried out at the
ASLMB since 2005. Here, 763 GPs were employed and over one million
people were assisted. The experimentation was aimed to improve the
care of patients with some chronic diseases through the definition of
shared clinical pathways adopted at the different levels of care, accord-
ing to a logical analysis of the system. The clinical pathways that were
targeted in 2005 were chronic obstructive bronco-pneumopathy
(COBP), diabetes, heart failure and patients undergoing anticoagulant
therapy. Since 2007, clinical pathways for hypertension and depression
have been added to the project. For all these pathologies, GPs were
requested to provide diagnostic and/or therapeutic support to special-
ists’ clinical practice.
Out of a total of 763 registered GPs, 95 (12%) took part in the first
phase of the experiment (2005-2006). Subsequently, (2007-2008) the
number of GPs taking part in the project every year was between 15 and
20% of the total number of GPs employed in the ASLMB.
The objective of the project was to implement clinical governance of
some chronic diseases through shared procedures of primary and spe-
cialised care,15 with an expected development of quality in primary
care. The expected results of the experimentation were conforming
GPs’ practice to experimental clinical pathways and allowing them to
become more involved in patients’ primary care, improving compliance
and patient satisfaction, as well as increasing GPs’ professional satis-
faction.
Specific use and adoption indicators (COBP, diabetes, heart failure,
arterial hypertension, depression) were formulated to monitor and
evaluate the pathways followed. Monitoring and evaluation showed an
on average higher level of compliance to care standards and better
results regarding patients’ hospitalisation; this decreased in compari-
son with the hospitalisation of those patients not included in the clini-
cal pathways experimentation.
For those patients who were included in the experimentation there
was: i) a higher rate of diagnostic/therapeutic interventions, consid-
ered to be a means of tracking the clinical pathways; ii) an overall
reduction in the use of use drugs and medicines and, therefore, lower
expenditure per capita; iii) a reduction in specialised day hospital care;
iv) fewer hospitalisations; and v) an improved compliance to pre-
scribed treatments. This was also found in other contexts where clini-
cal pathways have been implemented.16 The number of patients with
chronic disease included in the project has increased from 2388 in 2005
(i.e. 4% of the total of ASLMB patients with the pathologies selected) to
16,889 in 2008 (11% of the total). Those cared for within the project
took advantage of a greater number of sessions, evaluated for the proj-
ect as compliance tracking (e.g. in diabetes: electrocardiogram, fundus
oculi testing, glycated hemoglobin, microalbuminuria). At the same
time, there was a reduced rate of hospitalisation (both inpatient and
day hospital). As far as patients’ use of resources is concerned, data for
2005-2007 report that patients with diabetes, (COBP) and heart failure
followed by doctors involved in the experimentation showed an overall
trend for a decrease in the per capita expenditure for outpatient spe-
cialist care, hospitalisation and pharmaceutical assistance in the local
area.17
Besides objective indicators, it was considered useful to evaluate
GPs’ perception of the project. It is widely accepted that the opinion of
those taking part in the experimentation is a fundamental component
of its evaluation.
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Design and MethodsStudy design
A qualitative study was designed to evaluate the GPs’ perception of
the clinical pathways' experience.18 Qualitative research tends to focus
on the meaning that a certain experience has had for certain people,
exploring what factors influence making meaning of that experience.19
The study was aimed at encouraging GPs to reflect on their experi-
ence, at revealing critical issues and identifying possible lines of imple-
mentation. In addition, given the concept that adult education is main-
ly based on learning from experience20 and that this process is fostered
by reflection,21 discussion with other GP colleagues was considered an
important occasion for reflective learning on the clinical pathways'
experience. Besides contributing in a practical manner to the evalua-
tion of the project, the reflective practice fostered by focus groups has
been set up as a strategy to develop GPs learning from their own per-
sonal experience and, therefore, an opportunity for continuing profes-
sional development.
Participants
A specific sampling procedure was carried out in line with the tech-
niques of qualitative research sampling, that use non-representative
sampling methods.18 A first group of participants considered to be
important to the investigation identify other subjects who should be
approached (snowballing sampling). Through this sampling technique,
24 physicians from ASLMB were recruited. These were considered
expert informants about the clinical pathways' experience and were
randomly subdivided into two Focus Groups (FG1 and FG2) which met
in June 2008. After receiving the participants’ informed consent and
confirming confidentiality, the groups’ discussions were recorded and
transcribed verbatim. No patient data were collected. Ethical
Committee approval was not sought, since in Italy this is not required
for non-experimental studies involving healthcare professionals.
After the second FG, we noticed that the same ideas and feelings
were reported about the clinical pathways experimentation by partici-
pants in both groups. Data saturation was, therefore, achieved with the
two scheduled encounters and no more FGs were planned.
Data collection
Data were collected through focus groups.22,23 GPs were invited by
one of the investigators to participate in the study. All focus group
meetings were led by two moderators who were supported by a third
researcher, who took field notes.
The FG is a group discussion led by one or more interviewers follow-
ing a specific questioning route. This is a data gathering technique
used in qualitative studies, aimed at evaluating a particular experi-
ence, such as the introduction of guidelines in general practice.24-27
Besides recording their perceptions of the experience, the FGs provid-
ed opportunities for GPs to exchange their points of view. Hence, the
FG was considered not only a means of collecting data, but also proved
to be an approach that could encourage GPs’ to reflect on their experi-
ence and, therefore, promote their professional development. For this
reason, the two FGs were accredited as CME events.
The questioning route prepared for the FGs with the GPs taking part
in the experimentation is shown in Table 1.
Data analysis
The complete transcriptions of the two FGs were analysed by two
blinded researchers  according to the Interpretative Phenomenological
Approach.19 This method of analysis involves different steps:
the autonomous identification of some of the recurrent concepts in
a text and their indexing (labelling);
the comparison between the two researchers of the identified labels,
their homogeneity and their formalisation;
labelling all texts to be analysed according to the previously defined
labels;
the autonomous grouping by each of the researchers of labels which
are similar to each other in some categories;
the comparison between the researchers of the categories that
emerged;
the autonomous identification by each of the researchers of possible
macro-categories/themes which in turn include different categories;
the comparison between the researchers of the emerged macro-cat-
egories to identify an agreement as to which categories come under
which macro-category/theme.
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Table 1. The questioning route of the focus group.
• Presentation of  the chairmen and of aim and objectives of the focus group.
• Short introduction to the focus group
• Collection of the informed consents to taping of the meeting
• Information about policy on privacy
• Do you know each other? Would you introduce yourselves?
• How would you explain to a colleague GP from an other district the aim of this project? Let  us try to express the meaning of it using a short sentence.
• What do you think in general about clinical pathways? Which relationship do you see between clinical pathways and the project you have got involved in?
• Which added  value do you perceive for having been involved? What did you get?
• Instead which added value do you perceive for your patients? What did they get?
• Which choices, which activities could contribute to improve this project in your opinion? Please be as much precise as you can.
• How do you perceive the future development of this project? 
• Let us summarize the main points that have emerged from the discussion…
• Do you want to make some other remarks?
• What is the final remark you want to say in order to make this project implemented by your district?
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Rigour
During FGs, the researchers continuously triangulated with partici-
pants their understandings of the gathered data. 
Before analysing the transcripts, two researchers made explicit their
pre-conceptions regarding the experience of clinical pathways. The
researchers first performed all the steps of the data analysis individu-
ally and then discussed their findings together until an agreement was
found. In each step of the analysis the researchers kept a reflexive atti-
tude toward the phenomenon under study, considering continuously
alternative interpretations of the participants’ phrases and finally
grounding their analysis on the transcriptions.28
Findings
Thirteen GPs took part in focus group 1 (FG1) and 11 GPs took part
in focus group 2 (FG2). Average age of participants was 51.9 years in
FG1 and 53.2 years in FG2. Median number of years of experience as a
GP was 22 in FG1 and 23 in FG2. Average period of participation in the
project of clinical pathways was 2.5 years for both FG1 and FG2.
Therefore, both FG1 and FG2 are to be considered homogeneous for
age, professional experience and participation in the project.
After analysing the two FGs by the method described above, a high
consistency was found between labels, categories and themes that
emerged from the two sessions. Results of the two FGs are,  therefore,
presented together while still indicating the interviewee code and the
related FG that he/she attended. Four main themes emerged.
i) GPs perceive the clinical pathways in a positive light and
see them as a means to acquire/make visible a rigorous, effi-
cient and effective work method
GPs consider the clinical pathways' experience to be a positive one
in so far as they represent an articulated project of clinical governance
which, through the supply of diagnostic action and cure of chronic dis-
eases, allows doctors to increase their involvement in caring for their
patients and in their management:
The clinical pathway allowed us to concentrate on patient manage-
ment within the outpatient unit and for the GP to become the case man-
ager (GP1, FG2).
The clinical pathways' experience was considered to be positive for
the doctors in so far as it provided a tool for their work, tied to the
Evidence Based Medicine (EBM) guidelines; it made patient care and
treatment more efficient and effective, and strengthened the GP's
working method, while identifying skills which would otherwise
remain hidden.
[The clinical pathways' experience] improved a methodology of work
founded on a scientific basis and guidelines (GP6, FG1).
[It fosters] a scientific mentality (GP1, FG2).
[Clinical pathways' experiences] make the GPs’ work more visible
(GP1, FG2). 
According to some interviewees, the clinical pathway experience was a
positive one not only because it was able to improve the effectiveness of
GPs’ intervention, but also because it made their practice more efficient:
Patients’ care was made more effective from a curative and therapeu-
tic point of view while saving energy (GP9, GH1).
For these reasons, many GPs believe the clinical pathways experi-
ence represents a point of no return, mainly cultural (GP1, FG1), in
that it designs:
The philosophy of the future (GP1, FG1) and provides
An essential model of caring for the patient to refer to (GP7, FG1).
ii) The clinical pathways' experience increased both patient’s
and doctor’s satisfaction, since it sustains a caring approach
and strengthens the GP’s role
Many GPs agree that their participation in the project has allowed
them to follow the patient more accurately (MMG6, FG1). This meant:
Improved ability of taking care of the patient (GP5, FG1);
Patient satisfaction and appreciation (GP10, FG1);
A remarkable saving in terms of social costs of care for the patient
(GP1, FG2).
In addition, the figure of the GP emerged clearly strengthened (GP4,
FG1) because:
[Clinical pathways gave us] the possibility of widening knowledge
and improving our method (GP6, FG1); 
Improvement of our own performance and gain in credibility (GP3,
FG2).
Furthermore, GPs established relationships with hospital specialists,
acquired team work abilities and widened their professionalism.
A whole different world of relationships was opened up... We created
a series of links [with specialists which created new] opportunities and
possibilities which go beyond the clinical pathways' experience (GP3,
FG2);
Specialists, colleagues and office personnel worked together (GP9,
FG2).
Above all, the GPs felt they went back to filling a clinical role, which
had been lost because of increasing bureaucracy in the Italian primary
care system.
I had the sensation of having gained value as a doctor (GP7, FG2);
The good thing about the clinical pathways is taking back patient’s
management into our own hands, something that had been taken away
from us (GP4, FG2).
iii) Clinical pathways' experiences increase the bureaucratic
workload and problems can arise in relationships among GPs
and LHA
Time and commitment required to the GPs for participating in clini-
cal pathways' eperiences can be a heavy burden, since they require
adherence to highly standardised procedures.
The clinical pathway created a standardised  way to work with the
patients (GP8, FG2);
The clinical pathway has clipped our wing” (GP9, FG2).
According to GPs, participating in the clinical pathways' experience
involved a heavier bureaucratic workload, which could produce adverse
effects:
[It was] a race against time (GP2, FG1);
I am very angry about the bureaucracy… Paper work… Forms to fill
in (GP3, FG2).
Participating in the project did indeed require constant reporting to
the LHA of the work carried out. Many GPs saw this as a hard task,
since such reporting was so time consuming and was not sustained by
adequate administrative and technological resources. The experimen-
tal project did, therefore, create some difficulties in GPs’ relations with
the LHA. These were mainly:
Difficulties in reporting and communications with the LHA personnel
(GP12, FG1);
Difficulties in the LHA’s monitoring of the situation (GP1, FG1).
iv) Implementation of the clinical pathways could be improved
by slimming down the management administration procedures
and guaranteeing continuity
To improve the implementation of the clinical pathways' experience
in primary care, many interviewees mentioned the importance of man-
agement organisation. In particular, simplification and uniformity at all
levels of organisation, promoting traceability and control of work
undergone through reporting methods, which do not result in further
management-administrative burden, were all considered crucial strate-
gies to improve the implementation of clinical pathways in general
practice.
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The LHA must provide a reporting method which facilitates the doc-
tor’s work (GP12, FG1);
It would be better to have clear indicators of results rather than hav-
ing to keep piles of paper to be thrown away (GP3, FG2).
A further suggestion was to create an intermediary figure who oper-
ates between the GP and the LHA; somebody who is responsible for col-
lecting the data relating to the experimental project. Furthermore, the
LHA should better define the role of both the GP and the specialist,  cre-
ate a common project and a network, give space to the GPs, expanding
their tasks in caring for the patients.
[We need] to define our role [...] and define the role of the specialists
(GP1, FG1);
The leap in quality, in any case, can be made when the regional
authorities or the Local Health Authority, or whoever, understands that
they don’t need to find additional resources for these experimental proj-
ects but they need to diversify the tasks (GP1, FG2).
In the midst of this process of improvement, a key point seems to be
the need for continuity and the long-term profile of the project:
[It is important to have] the certainty that the project will continue
(GP5, FG2).
Considering the efforts that are involved in the introduction of clin-
ical pathways in general practice, it seems that GPs ask for guaranties
in the continuity of the project, since they do not want their efforts to
go to waste. According to GPs, the patients should also be more involved
and must be educated to assume greater responsibility in the caring
process. This could enable patients to make informed and shared choic-
es related to the diagnostic or therapeutic decisions made by GPs par-
ticipating in the experimentation.
If the citizen, who is at the centre of the system, is not educated he/she
is not capable of participating in the choices about his/her health (GP3,
FG2). 
Furthermore, it is important to share the experience of the project
among GPs and invest in training in order to involve a greater number
of practitioners in the project.
[It is necessary to] hold specific courses, carried out seriously (GP10,
FG2).
Finally, the interviewees pointed out the huge implications of the
experiment regarding motivation. Sharing the experience among GPs,
having the possibility of working together, receiving training on clini-
cal pathways and, therefore, updating individual experience, are all ele-
ments which could make you feel less alone because, as one intervie-
wee pointed out, working together, finding solutions together [for the
problems that arise from clinical practice], are an excellent antidote to
burn out (GP3, FG2).
Discussion 
Since this is a qualitative study, no generalisations can be made of
the findings, either for all the GPs who took part in this experimental
project or for other GPs who are/will be involved in similar projects in
the future. Nonetheless, the purposive sampling carried out (consid-
ered the gold standard for this type of study), together with the contin-
uous debate and discussion with the participants of the emerging data
during the FGs, make these results highly reliable. The study, therefore,
does not give certainties, but rather identifies trends regarding the dif-
ficulties which may have to be met by administrators who intend to
implement an experimental clinical pathway in contexts similar to the
one described here. For this reason, this study can only provide some
suggestions, to be verified in the field, to the design and implementa-
tion of experimental clinical pathways in other LHAs.
From the analysis of these findings, it emerges that the participants
perceive the experiment to be a generally positive one. According to the
participants, the experimental clinical pathways' experience not only
results in a more effective and efficient treatment, restoring responsi-
bility for the patient, but it also has a positive impact on the GP who,
through this pathway, can apply scientific evidence of some of the diag-
nostic and therapeutic processes and adopt a more rigorous working
method. This point seems to be related to the desire to do the right
thing7 that has been shown to be a powerful motivational factor for
Australian GPs in the uptake of guidelines. In fact, experimental clini-
cal pathways' experiences, probably because of the evidence on which
they are based and the work method which they foster, seem to allow a
greater control of the work of each doctor, starting up processes of con-
tinuous improvement and self-training that can be expanded through
audits. For these reasons, the Italian doctors who took part in this
experiment consider the experimental clinical pathways to be a point
of no return. The value of the methodology, acquired thanks to a clini-
cal pathways' experience, could be an element to be put to good advan-
tage when they are introduced and implemented in other LHA.
Clinical pathways can improve patient satisfaction with treatment
and therapy. Italian doctors felt they regained their professional
responsibility, that patients felt themselves to be followed more careful-
ly, and believed that being able to benefit from diagnostic procedures in
their GP’s office makes those procedures easier to carry out and more
comfortable. This result, in line with that of Jones et al.,11 seems to
suggest that the introduction of clinical pathways in general practice
can improve doctor-patient relationships. Naturally, this is the GPs’
point of view on patients’ reactions to the clinical pathways' experi-
mentation, and it should be examined in more detail with the patients,
even though often doctors have reported their comments, directly using
the same colloquial and dialectal language. Therefore, GPs suggest that
an important purpose of the experiment, which was to heighten doc-
tors’ sense of responsibility in caring for their patients and increase
their own satisfaction in the care delivered, has been reached.
Furthermore, the experimental clinical pathways' experience seems to
improve the GP’s image, restoring his/her diagnostic/therapeutic pro-
file, increasing professional satisfaction and creating the ideal condi-
tions in which to improve their relationship with specialists. This
means that also the purpose of putting professional satisfaction to good
use seems to have been reached. These aspects of patients’ and GPs’
satisfaction should be taken into consideration in the phase of intro-
duction/implementation of experimental clinical pathways.
Participation in the experiment showed, however, that there are
some obstacles to its full realisation. Firstly, experimental clinical path-
ways require the creation of closer and more complex relationships
both with colleagues, with specialists and with the LHA, which are not
always easy to manage. Secondly, there are more important obstacles
related to the extra amount of time required for the GPs to participate
in the experiment, not only due to the extra diagnostic and therapeutic
performed activities, but also due to the time spent in reporting those
activities to the LHA (the so called paper work). This is in line with
what has been pointed out by Saunders and colleagues.7 As a conse-
quence, GPs claim they need greater resources to allow clinical man-
agement and that a lack of resrouces has a negative impact on their
motivation, above all when scarsity of resources had to be managed
alongside an increase in workload. 
When introducing clinical pathways in general practice, it seems,
therefore, important to pay particular attention to the aspects of admin-
istrative management, for example making reporting to LHA easier by
slimming down procedures and training personnel and/or intermediary
figures aimed at facilitating the reporting process. As far as organisa-
tion is concerned, GPs offer some indications of how to improve the
experimental clinical pathways' experience. Firstly, by investing the
money saved in hospital care in the general practice. One aspect which
was particularly emphasised by the Italian GPs was the need to inte-
grate teams of professionals and to give them adequate tools. GPs ask
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for a precise definition of their role and the work required of them by
the experimental clinical pathway. Again, implementation of the clini-
cal pathways in general practice seems to require the creation of a part-
nership between the different individuals involved. Patients’ education
and the development of a greater sense of clients’ responsibility could
represent a further investment that would put patients in a position to
be able to exercise their own freedom of choice and, therefore, empow-
ering them.
Finally, our experience seems to indicate the importance of the conti-
nuity of this type of experimentations; there is no room for improvisa-
tion. Once the experimental phase was concluded, the ASLMB has con-
tinued to propose similar projects year by year. Nonetheless, in spite of
the positive results of the experience, the lack of guaranteed resources
in the long-term to invest in the organisational development of primary
care has created limitations as to how far the experience can be extend-
ed. This is in spite of the fact that many GPs have themselves asked for
the clinical pathways' experience to be continued and extended.
Conclusions
Our FGs on the experimental clinical pathways' project in primary
care carried out by the ASLMB reveal that on the whole the experience
was perceived as a positive one. In fact, GPs declared that the experi-
ence had enhanced their caring attitude for the patients, had given
them access to material and human resources that would otherwise
have been inaccessible, and allowed them to work in direct contact with
hospital specialists, with a consequent improvement in their own pro-
fessional skills and image. Such benefits are perceived in contrast to
the problems and obstacles concerning the highly standardised proce-
dures that require additional temporal and economic resources  for
their management. These problems influence the GPs’ motivation to
adopt the guidelines proposed. In order to implement the experimental
project, managerial aspects should be improved while at the same time
its continuity should be guaranteed.
Finally, the focus group proved itself to be a valid tool that could be
applied to data collection of the perceptions of the experimental clini-
cal pathways' experience. It was also an effective strategy for compari-
son and discussion and, therefore, for GPs’ continuing professional
development.
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